Patients with primary sclerosing cholangitis with and without end-stage liver disease have similar outcomes after liver transplantation

Figure 1 Overall survival, recurrent primary sclerosing cholangitis, and graft failure following liver transplant in primary sclerosing cholangitis patients with end-stage liver disease vs non-end-stage liver disease indications. A: Overall survival following liver transplant in patients with primary sclerosing cholangitis. Intergroup differences were not significant (P = 0.78, log-rank test); B: Occurrence of recurrent primary sclerosing cholangitis following liver transplant in patients with primary sclerosing cholangitis. Intergroup differences were not significant (P = 0.78, log-rank test); C: Occurrence of graft failure following liver transplant in primary sclerosing cholangitis patients with primary sclerosing cholangitis. Intergroup differences were not significant (P = 0.878, log-rank test). 1: End-stage liver disease; 0: Non-end-stage liver disease.